TopGum announces acquisition of PharmItBe, appoints new head of R&D
Head of R&D is now Dr. Evgenia Lozinsky, former CEO of PharmItBe.
Functional gummy supplement manufacturer TopGum Industries, Ltd., has announced the signing of an agreement to purchase PharmItBe, Ltd. and named Dr. Evgenia Lozinsky, former CEO of PharmItBe as TopGum’s head of R&D. TopGum will use PharmItBe’s fully equipped, FDA certified laboratory to access comprehensive chemical-analytical services. This will ensure strict quality standards are maintained, even while condensing lead-time for the supply chain process. In addition, PharmItBe’s R&D capabilities will accelerate TopGum’s pharma-grade gummies development for a new facility. The plant, supported by a U.S. $40 million investment, is scheduled to be operational by the end of this year.
PharmItBe was founded by Dr. Evgenia Lozinsky, PhD in 2016 as an FDA-certified advanced analytical laboratory that develops formulations and new delivery formats as well as providinganalytics laboratory services to international pharmaceutical, dietary supplement, and food companies. Following the acquisition, Lozinsky will serve as VP of R&D for TopGum. She will oversee all R&D activities of the company, including innovating new products for customers, developing a unique microencapsulation formula, creating products for the new state-of-the-art TopGum facility, and leading the development of pharma-grade OTC gummies.